Type and Press enter
Menu

PHARMACOVIGILANCE

We strictly follow all relevant legal provisions and regulations and, additionally, we implement complementary internal quality control procedures in order to acquire a thorough and well-documented understanding of the product’s safe management before we launch it to the market.

Safety profile inspection is continuously evaluated for all drugs in the market, by assessing the product’s risk/benefit ratio.

Being aware of the high responsibility we bear and having health protection and legal compliance always in mind, we implement an integrated pharmacovigilance system which:

  • Includes an in-house Qualified Person for Pharmacovigilance in the European Economic Area (EEA QPPV) and an external partner with many years of experience and specific qualifications in the Healthcare sector.
  • Conducts regular training programs on pharmacovigilance issues, which are organized for the company’s HR.
  • Sees to the effective and functional communication with the pharmaceutical authorities, with Health Professionals and with patients in order to receive reports on adverse reactions.
  • Has a regular communication with all control and production networks of the companies we represent and with official bodies in Greece and in the European Union, in order to acquire direct and valid information on the pharmaceutical products we offer.

Please inform us on any adverse reaction related to any of our company’s drugs in one of the following ways:

Mail-icon+30 210 6136332 (working days and hours)

 

Mail-icon+30 210 8045712 (non working days and hours)

 

Mail-iconvigilance@aenorasis.com

 

Mail-iconComplete the Adverse Reaction Report e-form

    ADVERSE REACTION REPORT FORM

    Please fill in the following information in order to report any adverse reaction that has appeared on the patients who receive a pharmaceutical product of our company.









    On your report, please include as much information as possible, including information on the patient's medical history, any co-administered drugs, as well as the date of the beginning of the treatment and other adverse reactions.

    footer-logo
    Aenorasis is a Greek company with successful operation in the Health care sector since 1998, which offers a wide range of effective diagnostic and therapeutic solutions.

    CONTACT US
    • Head Offices
    • Trapezountos 17 & Α. Papandreou Avenue
    • 151 27, Melissia
    • Τel.: +30 210 6136332
    • Fax: +30 210 8105298
    • Email: info@aenorasis.com
    • Registration Number: 002926501000
     
    • Thessaloniki Office
    • Delphon 17,
    • 555 35 Pylaia, Thessaloniki
    • Tel.: +30 2310 326136
    • Fax: +30 2310 306790
    LINKS
    FINANCIAL STATEMENTS

    Cookies Settings

    Choose which cookies you want to allow.

    • Remember which cookies group you accepted

    • Remember your login details
    • Essential: Remember your cookie permission setting
    • Essential: Allow session cookies
    • Essential: Gather information you input into a contact forms newsletter and other forms across all pages
    • Essential: Keep track of what you input in a shopping cart
    • Essential: Authenticate that you are logged into your user account
    • Essential: Remember language version you selected
    • Functionality: Remember social media settings
    • Functionality: Remember selected region and country
    • Analytics: Keep track of your visited pages and interaction taken
    • Analytics: Keep track about your location and region based on your IP number
    • Analytics: Keep track of the time spent on each page
    • Analytics: Increase the data quality of the statistics functions
    • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
    • Advertising: Gather personally identifiable information such as name and location

    Save & Close